Eden Research PLC
LSE:EDEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (0), the stock would be worth GBX-0.02 (100% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -11 | GBX3.6 |
0%
|
| Industry Average | 0 | GBX-0.02 |
-100%
|
| Country Average | 0 | GBX-0.01 |
-100%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Eden Research PLC
LSE:EDEN
|
28.9m GBP | -11 | -8.2 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.5B USD | 19.1 | 48.6 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
47.1B CAD | 12.4 | 15.1 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
188.9B CNY | 24.2 | 22.7 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
24.4B USD | 26.7 | 41.6 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
137.1B CNY | 81.3 | 29.3 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
19.3B USD | 8.8 | 13.3 | |
| NO |
|
Yara International ASA
OSE:YAR
|
137.1B NOK | 10 | 10.5 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 10 | 12.4 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
912.2B RUB | 6 | 7.9 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
77.1B CNY | 18.6 | 23.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 015 |
Other Multiples
Eden Research PLC
Glance View
Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 11 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products are formulated with terpene ingredients, which are based on natural plant defense metabolites. The Company’s products include Mevalone and Cedroz. Mevalone is a foliar bio-fungicide, which is focused on diseases affecting grapes, and other fruit and vegetable crops. Cedroz is a bionematicide that targets free living nematodes, which are parasitic worms that affect a range of fruit and vegetable crops globally. The Company’s subsidiary is TerpeneTech (Ireland) Limited.
